Reproduction in couples who are affected by human immunodeficiency virus: Medical, ethical, and legal considerations

被引:13
作者
Williams, CD [1 ]
Finnerty, JJ [1 ]
Newberry, YG [1 ]
West, RW [1 ]
Thomas, TS [1 ]
Pinkerton, JV [1 ]
机构
[1] Univ Virginia, Hlth Syst, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil,Sch Med, Charlottesville, VA 22903 USA
关键词
human immunodeficiency virus; conception; pregnancy; infertility; ethics; legal;
D O I
10.1067/S0002-9378(03)00676-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
There has been a transformation in the treatment of human immunodeficiency virus from the treatment of complications that define acquired immune deficiency syndrome to the maintenance of long-term health, with an expanding number of antiretroviral medications. Because human immunodeficiency virus infection now is considered to be a chronic disease, couples will be seen in greater numbers for preconception counseling. The ethical and legal implications, including the relevance of the Americans with Disability Act, are complex but support the assistance with reproduction of couples who are affected by human immunodeficiency virus in many instances. All couples who are affected by human immunodeficiency virus, whether fertile or infertile, who want to have genetically related offspring should be seen preconceptionally for counseling and testing. Intensive education involves a multidisciplinary approach to ensure that a couple is fully informed. Determination of whether to offer treatment should be based on the same criteria that are applied to couples who are affected by other chronic diseases. Medical treatment is dependent on the unique circumstances of each couple. In general, the affected partner(s) should be treated aggressively with antiretrovirals and then serum; if applicable, semen testing is required to document undetectable concentrations of human immunodeficiency virus (<50-100 copies/mL).
引用
收藏
页码:333 / 341
页数:9
相关论文
共 32 条
[1]  
Aebi C, 2000, AIDS, V14, P2913, DOI 10.1097/00002030-200012220-00013
[2]  
[Anonymous], SCHED CES DEL PREV V
[3]  
Baccetti B, 1999, J ACQ IMMUN DEF SYND, V21, P355
[4]   The debate on the presence of HIV-1 in human gametes [J].
Baccetti, B ;
Benedetto, A ;
Collodel, G ;
di Caro, A ;
Garbuglia, AR ;
Piomboni, P .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1998, 41 (1-2) :41-67
[5]  
BOLAN G, 2002, AUDIO DIGEST OBSTET, V49
[6]   The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis [J].
Brocklehurst, P ;
French, R .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1998, 105 (08) :836-848
[7]   Pregnancy outcome among HIV positive and negative intravenous drug users [J].
Bucceri, A ;
Luchini, L ;
Rancilio, L ;
Grossi, E ;
Ferraris, G ;
Rossi, G ;
Vignali, M ;
Parazzini, F .
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1997, 72 (02) :169-174
[8]   The influence of pregnancy on human immunodeficiency virus type 1 infection: Antepartum and postpartum changes in human immunodeficiency virus type 1 viral load [J].
Burns, DN ;
Landesman, S ;
Minkoff, H ;
Wright, DJ ;
Waters, D ;
Mitchell, RM ;
Rubinstein, A ;
Willoughby, A ;
Goedert, JJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1998, 178 (02) :355-359
[9]  
Childress JF., 2001, PRINCIPLES BIOMEDICA
[10]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180